Bg pattern

RISPERIDONE TEVA 37.5 mg POWDER AND SOLVENT FOR PROLONGED-RELEASE INJECTABLE SUSPENSION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use RISPERIDONE TEVA 37.5 mg POWDER AND SOLVENT FOR PROLONGED-RELEASE INJECTABLE SUSPENSION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet:information for the user

Risperidone Teva 25 mg powder and solvent for prolonged-release injectable suspension EFG

Risperidone Teva 37.5 mg powder and solvent for prolonged-release injectable suspension EFG

Risperidone Teva 50 mg powder and solvent for prolonged-release injectable suspension EFG

Read all of this leaflet carefully before you start using this medicine,because it contains important information for you.

  • Keep this leaflet, as you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • If you experience any side effects, talk to your doctor or pharmacist, even if they are not listed in this leaflet. See section 4.

Contents of the package leaflet

  1. What is Risperidone Teva and what is it used for
  2. What you need to know before you use Risperidone Teva
  3. How to use Risperidone Teva
  4. Possible side effects

5 Storage of Risperidone Teva

  1. Contents of the pack and other information

1. What is Risperidone Teva and what is it used for

Risperidone belongs to a group of medicines called “antipsychotics”.

Risperidone is used in the maintenance treatment of schizophrenia, which is characterized by seeing, hearing, or feeling things that are not present, believing in something that is not true or unusually feeling distrust or confusion.

Risperidone is intended for patients who are currently being treated with oral antipsychotics (e.g., tablets, capsules).

Risperidone may help reduce the symptoms of your illness and prevent them from coming back.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use Risperidone Teva

Do not use Risperidone Teva

  • if you are allergic to risperidone or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

  • If you have never taken risperidone in any of its forms, you must start with oral risperidone before starting with this medicine.

Talk to your doctor or pharmacist before starting to use Risperidone Teva if:

  • You have a heart problem. For example, an irregular heartbeat, or if you are prone to having low blood pressure or if you are using medicines for blood pressure. Risperidone may lower your blood pressure. Your dose may need to be adjusted.
  • You know you have any factor that makes you prone to having a stroke, such as high blood pressure, cardiovascular disorders, or cerebral circulation disorders.
  • You have ever had involuntary movements of the tongue, mouth, and face.
  • You have ever had symptoms that include fever, muscle stiffness, sweating, or a decrease in the level of consciousness (also known as Neuroleptic Malignant Syndrome).
  • You have Parkinson's disease or dementia.
  • You have had low white blood cell counts in the past (which may or may not have been caused by other medications).
  • You are diabetic.
  • You have epilepsy.
  • You are male and have ever had a prolonged or painful erection.
  • You have difficulty controlling your body temperature or feel excessive heat.
  • You have kidney problems.
  • You have liver problems.
  • You have an abnormally high level of a hormone called prolactin in your blood or if you have a tumor that may be dependent on prolactin.
  • You or a family member have blood clotting problems, as medications like this have been associated with the formation of blood clots.

If you are unsure about any of the above, talk to your doctor or pharmacist before using risperidone or Risperidone Teva powder and solvent for prolonged-release injectable suspension EFG.

Because it has been rarely observed in patients treated with risperidone that there is a dangerously low number of a type of white blood cells necessary to fight infections in the blood, your doctor may check your white blood cell count.

Rarely, allergic reactions have occurred after receiving risperidone injections, even if you have previously tolerated oral risperidone. Seek immediate medical attention if you experience hives, throat swelling, itching, or breathing problems, as these may be symptoms of a severe allergic reaction.

Risperidone may cause you to gain weight. A significant weight gain can unfavorably affect your health. Your doctor will regularly monitor your weight.

Because diabetes mellitus or a worsening of pre-existing diabetes mellitus has been seen in patients taking risperidone, your doctor should check for signs of elevated blood sugar. In patients with pre-existing diabetes mellitus, blood sugar should be regularly monitored.

Risperidone often increases the levels of a hormone called “prolactin”. This can cause side effects such as menstrual disorders or fertility problems in women, or breast swelling in men (see Possible side effects). If these side effects occur, it is recommended to evaluate prolactin levels in the blood.

During eye surgery for cataracts, the pupil (the black circle in the middle of the eye) may not increase in size as needed. Additionally, the iris (the colored part of the eye) may become flaccid during surgery, which can cause eye damage. If you are planning to have eye surgery, make sure to inform your ophthalmologist that you are using this medication.

Elderly patients with dementia

Risperidone is not used in elderly patients with dementia.

If you or your caregiver notice a sudden change in your mental state or the sudden appearance of weakness or numbness in the face, arms, or legs, especially on one side, or confused speech, even if only for a short time, seek medical attention immediately. It may be a sign of a stroke.

Patients with kidney or liver problems

Although oral risperidone has been studied, Risperidone Teva powder and solvent for prolonged-release injectable suspension EFG has not been studied in patients with kidney or liver problems. Risperidone should be administered with caution in this group of patients.

Using Risperidone Teva with other medicines

Tell your doctor or pharmacist if you are using or have recently used or may need to use any other medicine.

It is especially important that you talk to your doctor or pharmacist if you are taking any of the following

  • Medicines that act on the brain used to calm down (benzodiazepines) or some pain medications (opioids), allergy medications (some antihistamines), as risperidone may increase the sedative effect of all these.
  • Medicines that can modify the electrical activity of your heart, such as those used for malaria, heart rhythm problems, allergies (antihistamines), some antidepressants, or other medicines for mental problems.
  • Medicines that can cause a decrease in heart rate.
  • Medicines that can cause a decrease in potassium levels in the blood (such as certain diuretics).
  • Medicines for Parkinson's disease (such as levodopa).
  • Medicines that increase the activity of the central nervous system (psychostimulants, such as methylphenidate).
  • Medicines for high blood pressure. Risperidone may lower blood pressure.
  • Diuretics used for heart problems or to treat swelling of some parts of the body due to fluid retention (such as furosemide or chlorthiazide). Risperidone, taken alone or with furosemide, may increase the risk of stroke or death in elderly patients with dementia.

The following medicines may reduce the effect of risperidone

  • Rifampicin (a medicine used to treat some infections).
  • Carbamazepine, phenytoin (medicines used to treat epilepsy).
  • Phenobarbital.

If you start or stop taking these medicines, you may need a different dose of risperidone.

The following medicines may increase the effect of risperidone

  • Quinidine (a medicine used to treat certain types of heart problems).
  • Antidepressants such as paroxetine, fluoxetine, tricyclic antidepressants.
  • Medicines known as beta-blockers (used to treat high blood pressure).
  • Phenothiazines (such as medicines used to treat psychosis or to calm down).
  • Cimetidine, ranitidine (medicines used to treat stomach acid).
  • Itraconazole and ketoconazole (medicines used to treat fungal infections).
  • Some medicines used to treat HIV/AIDS, such as ritonavir.
  • Verapamil, a medicine used to treat high blood pressure and/or abnormal heart rhythm.
  • Sertraline and fluvoxamine, medicines used to treat depression and other psychiatric disorders.

If you start or stop taking these medicines, you may need a different dose of risperidone.

If you are unsure about any of the above, talk to your doctor or pharmacist before using risperidone.

Using Risperidone Teva with food, drinks, and alcohol

You should avoid consuming alcohol while using risperidone.

Pregnancy, breastfeeding, and fertility

  • If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine. Your doctor will decide if you can use it.
  • The following symptoms may occur in newborn babies of mothers who have been treated with risperidone in the last trimester of pregnancy (last three months of pregnancy): trembling, stiffness and/or muscle weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your baby develops any of these symptoms, you should contact your doctor.
  • Risperidone may increase the levels of a hormone called “prolactin” that could affect your fertility (see Possible side effects).

Driving and using machines

Dizziness, fatigue, and vision problems have been observed during treatment with risperidone. Do not drive or use tools or machinery without consulting your doctor first.

Risperidone Teva contains sodium

This medicine contains less than 23 mg of sodium (1 mmol) per dose; it is essentially “sodium-free”.

3. How to use Risperidone Teva

Follow exactly the administration instructions of this medicine given by your doctor. In case of doubt, consult your doctor or pharmacist again.

Risperidone Teva is administered by intramuscular injection in the arm or buttock every two weeks, by a healthcare professional. The injections should be alternated between the left and right side and should not be administered intravenously.

The recommended dose is as follows:

Adults

Initial dose

If your daily dose of oral risperidone (e.g., tablets) was 4 milligrams or less during the two weeks prior, your initial dose should be 25 milligrams of Risperidone Teva powder and solvent for prolonged-release injectable suspension EFG.

If your daily dose of oral risperidone (e.g., tablets) was more than 4 milligrams during the two weeks prior, you may be given a dose of 37.5 milligrams of Risperidone Teva powder and solvent for prolonged-release injectable suspension EFG as the initial dose.

If you are currently being treated with another oral antipsychotic that is not risperidone, your initial dose of Risperidone Teva powder and solvent for prolonged-release injectable suspension EFG will depend on your current treatment. Your doctor will choose Risperidone Teva 25 mg or 37.5 mg.

Your doctor will decide if this dose of risperidone is suitable for you.

Maintenance dose

  • The usual dose is an injection of 25 milligrams every two weeks.
  • A higher dose of 37.5 or 50 mg may be necessary. Your doctor will decide which dose of risperidone is most suitable for you.
  • Your doctor may prescribe oral risperidone for the first three weeks after the first injection.

If you use more Risperidone Teva than you should

  • People who have used more risperidone than they should have experienced the following symptoms: drowsiness, fatigue, abnormal body movements, problems standing and walking, feeling dizzy due to low blood pressure, and abnormal heartbeats. There have been reports of anomalies in the electrical conduction of the heart and seizures.
  • Consult your doctor immediately or call the Toxicology Information Service, phone 91.562.04.20, indicating the medicine and the amount taken. It is recommended to take the package and the package leaflet of the medicine to the healthcare professional.

If you stop using Risperidone Teva

You will lose the effects of this medicine. Do not stop using this medicine unless your doctor tells you to, as you may experience the return of symptoms. Make sure to receive your injections every two weeks. If you cannot attend your appointments, contact your doctor immediately to schedule another appointment when you can.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

Use in children and adolescents

Children and adolescents under 18 years of age should not receive risperidone.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible Adverse Effects

Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.

Report immediately to your doctor if you experience any of the following rare adverse effects (may affect up to 1 in 100 patients):

  • You have dementia and experience a sudden change in your mental state or sudden weakness or numbness of the face, arms, or legs, especially on one side, or have difficulty speaking even for a short period. These may be signs of a stroke.
  • You experience tardive dyskinesia (involuntary spasms or rhythmic movements that cannot be controlled in the face, tongue, or other parts of the body). Report to your doctor immediately if you experience involuntary rhythmic movements of the tongue, mouth, and face. It may be necessary to withdraw risperidone.

Report immediately to your doctor if you experience any of the following very rare adverse effects (may affect up to 1 in 1,000 patients):

  • You experience blood clots in the veins, especially in the legs (symptoms include swelling, pain, and redness of the leg), which can circulate through the blood vessels to the lungs, causing chest pain and difficulty breathing. If you notice any of these symptoms, seek medical advice immediately.
  • You experience fever, muscle stiffness, sweating, or a decrease in the level of consciousness (a condition known as "Neuroleptic Malignant Syndrome"). You may need immediate medical treatment.
  • You are a man and experience a prolonged or painful erection. This is known as priapism. You may need immediate medical treatment.
  • You experience a severe allergic reaction characterized by fever, swelling of the mouth, face, lips, or tongue, difficulty breathing, itching, skin rash, or a drop in blood pressure. Even if you have previously tolerated oral risperidone, in rare cases, allergic reactions may occur after receiving risperidone injections.

The following adverse effects may also occur:

Very Common Adverse Effects(may affect more than 1 in 10 people)

  • Common cold symptoms
  • Difficulty staying or falling asleep
  • Depression, anxiety
  • Parkinsonism: This disease may include slow or altered movement, feeling of stiffness or tightness of the muscles (making sudden movements), and sometimes a feeling of "freezing" of movement that then restarts. Other signs of parkinsonism include walking slowly, dragging feet, resting tremor, increased saliva and/or drooling, and loss of facial expressiveness.
  • Headache.

Common Adverse Effects(may affect up to 1 in 10 people)

  • Pneumonia, chest infection (bronchitis), sinusitis
  • Urinary tract infection, feeling like you have the flu, anemia
  • Increased levels of a hormone called "prolactin" that is detected in blood tests (which may or may not cause symptoms). Symptoms of increased prolactin appear rarely and in men may include breast swelling, difficulty having or maintaining erections, decreased sexual desire, or other sexual dysfunctions. In women, they may include breast tenderness, milk secretion from the breasts, loss of menstrual periods, or other problems with the cycle or fertility issues.
  • Increased blood sugar, weight gain, increased appetite, weight loss, decreased appetite
  • Sleep disorder, irritability, decreased sexual desire, restlessness, feeling drowsy or less attentive
  • Dystonia. This disease involves slow or continuous involuntary contraction of the muscles. Although any part of the body can be affected (and can cause abnormal postures), dystonia often affects the muscles of the face, including abnormal movements of the eyes, mouth, tongue, or jaw.
  • Dizziness
  • Discinesia: This disease involves involuntary muscle movements and may include repetitive, spasmodic, or twisting movements, or spasms.
  • Tremor (shakiness)
  • Blurred vision
  • Rapid heartbeat
  • Decreased blood pressure, chest pain, increased blood pressure
  • Shortness of breath, sore throat, cough, nasal congestion
  • Abdominal pain, abdominal discomfort, vomiting, nausea, stomach or intestinal infection, constipation, diarrhea, indigestion, dry mouth, toothache
  • Skin rash
  • Muscle spasms, bone or muscle pain, back pain, joint pain
  • Urinary incontinence
  • Erectile dysfunction
  • Loss of menstrual periods
  • Milk secretion from the breasts
  • Body swelling, arm or leg swelling, fever, weakness, fatigue
  • Pain
  • A reaction at the injection site, including itching, pain, or swelling
  • Increased liver transaminases in the blood, increased GGT (a liver enzyme called gamma-glutamyltransferase) in the blood
  • Falls.

Uncommon Adverse Effects(may affect up to 1 in 100 people)

  • Respiratory tract infection, bladder infection, ear infection, eye infection, tonsillitis, fungal infection of the nails, skin infection, localized infection in a single area of the skin or body part, viral infection, skin inflammation caused by mites, abscess under the skin
  • Decreased number of white blood cells, decreased platelets (blood cells that help stop bleeding), decreased red blood cells
  • Allergic reaction
  • Sugar in the urine, diabetes, or worsening of diabetes
  • Lack of appetite that causes malnutrition and weight loss
  • Increased triglycerides in the blood (fat), increased cholesterol in the blood
  • Euphoria (mania), confusion, inability to reach orgasm, nervousness, nightmares
  • Loss of consciousness, seizures (epileptic fits), fainting
  • A restlessness that causes movement of body parts, balance disorder, abnormal coordination, dizziness when standing up, attention disturbance, speech problems, loss or alteration of taste, decreased skin sensitivity to pain or touch, sensation of tingling, pinching, or numbness of the skin
  • Eye infection or "red eye," dry eyes, increased tearing, eye redness
  • Feeling that everything is spinning (vertigo), ringing in the ears, ear pain
  • Atrial fibrillation (abnormal heart rhythm), interruption of conduction between the upper and lower parts of the heart, anomaly in the electrical activity of the heart, prolonged QT interval in the heart, slow heartbeat, anomaly in the electrical conduction of the heart (electrocardiogram or ECG), sensation of fluttering or pounding in the chest (palpitations)
  • Decreased blood pressure when standing up (as a consequence, some people taking risperidone may feel weakness, dizziness, or loss of consciousness when getting up or sitting down suddenly)
  • Rapid breathing, shallow breathing, respiratory congestion, wheezing, nasal bleeding
  • Fecal incontinence, difficulty swallowing, excess gas or flatulence
  • Itching, hair loss, eczema, dry skin, skin redness, skin discoloration, acne, scaly or itchy skin or scalp
  • Increased CPK (creatine phosphokinase) in the blood, an enzyme that is sometimes released with muscle breakdown
  • Joint stiffness, joint swelling, muscle weakness, neck pain
  • Frequent urination, inability to urinate, painful urination
  • Ejaculation disorder, delayed menstruation, loss of menstrual periods, or other problems with the cycle (women), development of breasts in men, sexual dysfunction, breast pain, breast tenderness, vaginal discharge
  • Facial swelling, mouth, eye, or lip swelling
  • Chills, increased body temperature
  • Change in gait
  • Feeling of thirst, feeling of discomfort, chest discomfort, feeling "unwell"
  • Hardening of the skin
  • Increased liver enzymes in the blood
  • Pain due to the procedure.

Rare Adverse Effects(may affect up to 1 in 1,000 people)

  • Decrease in a type of white blood cell that helps fight infections
  • Inadequate secretion of a hormone that controls urine volume
  • Low blood sugar
  • Excessive water intake
  • Sleepwalking
  • Sleep-related eating disorder
  • Lack of movement or response while awake (catatonia)
  • Lack of emotions
  • Decreased level of consciousness
  • Head agitation
  • Eye movement problems, eye rotation, hypersensitivity of the eyes to light
  • Eye problems during cataract surgery. During cataract surgery, a condition called intraoperative floppy iris syndrome (IFIS) may occur if you are taking or have taken risperidone. If you need to undergo cataract surgery, be sure to inform your ophthalmologist if you are taking or have taken this medication.
  • Irregular heartbeat
  • Dangerously low number of a type of white blood cell necessary to fight infections in the blood, increased eosinophils (a type of white blood cell) in the blood
  • Difficulty breathing during sleep (sleep apnea)
  • Pneumonia caused by aspiration of food, lung congestion, crackling sounds in the lungs, voice disorder, respiratory tract disorder
  • Pancreatitis, intestinal obstruction
  • Very hard stools
  • Drug-related skin rash
  • Hives (or "urticaria"), skin thickening, dandruff, skin disorder, skin lesion
  • Muscle fiber breakdown and muscle pain (rhabdomyolysis)
  • Posture abnormality
  • Breast enlargement, milk secretion from the breasts
  • Decreased body temperature, discomfort
  • Yellowing of the skin and eyes (jaundice)
  • Excessive water intake
  • Increased insulin (a hormone that controls blood sugar levels) in the blood
  • Brain blood vessel problems
  • No response to stimuli
  • Diabetic coma
  • Sudden loss of vision or blindness
  • Glaucoma (increased eye pressure), crusts on the eyelid margin
  • Flushing, tongue swelling
  • Cracked lips
  • Breast enlargement
  • Decreased body temperature, coldness in the arms and legs
  • Drug withdrawal symptoms.

Very Rare Adverse Effects(may affect up to 1 in 10,000 people)

  • Complications of uncontrolled diabetes, life-threatening
  • Severe allergic reaction with swelling, which can affect the throat, causing difficulty breathing
  • Lack of movement of the intestinal muscles, causing obstruction.

The following adverse effect has appeared with the use of another medicine called paliperidone, which is very similar to risperidone, so it is also expected to appear with risperidone: Rapid heartbeat when standing up.

Frequency Not Known:(cannot be estimated from the available data)

  • Severe skin rash with blisters and peeling of the skin that can start around the mouth, nose, eyes, genitals, and spread to other areas of the body (Stevens-Johnson Syndrome or toxic epidermal necrolysis).

Reporting of Adverse Effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.

5. Storage of Risperidona Teva

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiration date that appears on the packaging. The expiration date is the last day of the month indicated.

Store in the refrigerator (between 2°C and 8°C). If refrigeration is not available, the packaging can be stored below 25°C for a maximum of 7 days before administration.

Store in the original packaging to protect it from light.

After reconstitution:

Physical and chemical stability has been demonstrated for 24 hours at 25°C.

From a microbiological point of view, the product should be used immediately. If it is not used immediately, the conditions and storage times before use are the responsibility of the user and should not be more than 6 hours at 25°C, unless reconstitution has been carried out in controlled and validated aseptic conditions.

Medicines should not be thrown down the drain or into the trash. Deposit the packaging and medicines that you no longer need in the SIGRE point of the pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines that you no longer need. This way, you will help protect the environment.

6. Contents of the pack and additional information

Composition of Risperidone Teva

  • The active substance is risperidone.
  • Each Risperidone Teva powder and solvent for prolonged-release injectable suspension EFG contains 25 mg, 37.5 mg, or 50 mg of risperidone.
  • The other excipients are:

Powder for injection suspension:

Poly-(D, L-lactide-co-glycolide)

Solvent (solution):

Polysorbate 20, sodium carmellose, disodium hydrogen phosphate dihydrate, citric acid, sodium chloride, sodium hydroxide, water for injectables.

Appearance of the product and pack contents

Risperidone 25 mg:

Each pack contains the following components grouped in a plastic tray:

  • A small vial with a gray stopper, sealed with a pink aluminum cap, containing the powder (in this powder is the active substance, risperidone).
  • A preloaded syringe with 2 ml of clear, colorless liquid to add to the powder for prolonged-release suspension for injection.
  • A vial adapter for reconstitution.
  • Two Terumo SurGuard®3 needles for intramuscular injection: a 21G UTW safety needle, 1 inch (0.8 mm x 25 mm) with a needle protection device for administration in the deltoid, and a 20G TW safety needle, 2 inches (0.9 mm x 51 mm) with a needle protection device for administration in the gluteus.

Risperidone 37.5 mg:

Each pack contains the following components grouped in a plastic tray:

  • A small vial with a gray stopper, sealed with a green aluminum cap, containing the powder (in this powder is the active substance, risperidone).
  • A preloaded syringe with 2 ml of clear, colorless liquid to add to the powder for prolonged-release suspension for injection.
  • A vial adapter for reconstitution.
  • Two Terumo SurGuard®3 needles for intramuscular injection: a 21G UTW safety needle, 1 inch (0.8 mm x 25 mm) with a needle protection device for administration in the deltoid, and a 20G TW safety needle, 2 inches (0.9 mm x 51 mm) with a needle protection device for administration in the gluteus.

Risperidone 50 mg:

Each pack contains the following components grouped in a plastic tray:

  • A small vial with a gray stopper, sealed with a blue aluminum cap, containing the powder (in this powder is the active substance, risperidone).
  • A preloaded syringe with 2 ml of clear, colorless liquid to add to the powder for prolonged-release suspension for injection.
  • A vial adapter for reconstitution.
  • Two Terumo SurGuard®3 needles for intramuscular injection: a 21G UTW safety needle, 1 inch (0.8 mm x 25 mm) with a needle protection device for administration in the deltoid, and a 20G TW safety needle, 2 inches (0.9 mm x 51 mm) with a needle protection device for administration in the gluteus.

Risperidone Teva is available in packs containing 1, 2, or 5 dose packs.

Only some pack sizes may be marketed.

Marketing authorization holder and manufacturer

Marketing authorization holder

Teva Pharma, S.L.U.

C/Anabel Segura, 11 Edificio Albatros B, 1ª planta

28108 Alcobendas (Madrid)

Spain

Manufacturer

PLIVA Hrvatska d.o.o. (PLIVA Croatia Ltd.)

Prilaz baruna Filipovica 25

10000 Zagreb

Croatia

or

Pharmathen International S.A

Industrial Park Sapes,

Rodopi Prefecture, Block No 5,

Rodopi 69300,

Greece

or

Pharmathen S.A

Dervenakion 6,

Pallini Attiki,

15351, Greece

Date of the last revision of thisleaflet:March 2022

Detailed information on this medicinal product is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) (http://www.aemps.gob.es/)

----------------------------------------------------------------------------------------------------------------------------------

This information is intended only for healthcare professionals:

Important information

Risperidone Teva requires detailed attention at each step of the "Instructions for Use" to help ensure successful administration.

Use of the provided components

The pack components are specifically designed for use with Risperidone Teva.

Risperidone Teva should only be reconstituted with the solvent supplied in the pack.

Do notsubstitute anyof the components of this pack.

Do not store the suspension after reconstitution

Administer the dose as soon as possible after reconstitution to avoid sedimentation.

Appropriate dose

All the contents of the vial must be administered to ensure that the appropriate dose of Risperidone Teva is administered.

Black rectangular medical device with white text indicating 'SINGLE-USE DEVICE'

Do not reuse

Medical devices require materials with specific characteristics to function properly. These characteristics have been verified for single use. Any attempt to reprocess the device for subsequent reuse may negatively affect the integrity of the device or lead to deterioration of its function.

Pack components

Vial adapter with needle tip, edge, luer cap, and luer connection point indicated with linesPreloaded syringe with plunger, solvent, and white cap, showing white ring and plunger rod indicated

Transparent medication vial with microspheres inside and a light gray top capTerumo SurGuard®3 needle with transparent protector showing lengths for deltoid injection of 1 inch and gluteal injection of 2 inches

Step 1

Assemble the components

Remove the dose pack

Connect the vial adapter to the vial

Circular clock showing 30 minutes with ambient temperature indicated at 20°C to 25°C at the bottom

Hand turning the cap of a transparent vial with liquid and an arrow indicating the direction of opening

Hand holding an autoinjector with the protective cover partially removed for use

Hand holding a preloaded syringe with the plunger up and the needle exposed, ready for injection

Hand holding a vial with a transfer adapter and a connected syringe, black arrow indicating direction of injection

Wait 30 minutes

Remove the dose pack from the refrigerator and let it reach room temperature for at least 30 minutesbefore reconstituting.

Do not heat in any other way.

Remove the vial cap

Remove the colored cap from the vial.

Clean the top of the gray stopper with a cotton swab with alcohol.

Let it air dry.

Do notremove the gray rubber stopper.

Prepare the vial adapter

Open the blister pack and remove the vial adapter, holding it between the white luer cap and the edge.

Do nottouch the needle tip or the luer connection point at any time. This can lead to contamination.

Attach the vial adapter to the vial

Place the vial on a hard surface and hold it by the base. Center the vial adapter over the gray rubber stopper.

Press the vial adapter straight down until it clicks securely into place.

Do notplace the vial adapter at an angle, as this may cause loss of solvent during transfer to the vial.

Hand holding a vial and a needle, preparing for injection with a red cross indicating incorrect method

Attach the preloaded syringe to the vial adapter

Hand holding a vial with medication and another hand removing the protective cover of an injection needle

Clean the connection point

Keep the vial upright to prevent spills.

Hold the base of the vial and clean the luer connection point (blue circle) of the vial adapter with a cotton swab with alcohol and let it air dry before attaching the syringe.

Do notshake.

Do nottouch the luer connection point on the vial adapter.

This can lead to contamination.

Hand holding an autoinjector with the plunger pressed down to administer the injection

Use the correct grip area

Hold by the white ring of the syringe tip.

Do nothold the syringe by the glass during assembly.

Hand holding a syringe with the needle pointing down incorrectly over the skin

Hands holding an autoinjector with the tip pointing down and a sound of

Remove the cap

Holding the white ring, break the white cap.

Do nottwist or cut the white cap.

Do nottouch the syringe tip. This can lead to contamination.

Preloaded syringe with a removable gray protector showing the plunger and exposed needle

The broken cap can be discarded.

Hand holding a syringe connected to a needle, black arrow indicating direction of insertion into a medication vial

Attach the syringe to the vial adapter

Hold the vial adapter by the edge to keep it steady.

Hold the syringe by the white ring and then insert and press the syringe tip into the blue circle of the vial adapter and turn clockwise to secure the syringe to the vial adapter (avoid overtightening).

Do nothold the syringe by the glass cylinder.

This can cause the white ring to loosen or detach.

Step 2

Reconstitute the microspheres

Hand holding an autoinjector with the plunger pressed down on a transparent medication vial

Inject solvent

Inject all the solvent from the syringe into the vial.

White box with black text indicating instructions to press the plunger rod down with the thumb due to internal pressure

Hand holding an autoinjector with a timer showing 10 seconds and arrows indicating activation movement

Suspend the microspheres in the solvent

Continue pressing down the plunger with your thumb, vigorously shakefor at least 10 seconds, as shown.

Check the suspension.

When properly mixed, the suspension will have a uniform, dense, and milky appearance.

The microspheres will be visible in the liquid.

Immediately proceed with the next step to avoid sedimentation of the suspension.

Preloaded syringe with a transparent plunger and a hand holding it with the thumb pressing down

Transfer the suspension to the syringe

Invert the vial completely.

Slowly pull the plunger rod down to transfer all the contents of the vial to the syringe.

Hand holding a syringe connected to a circular device with a black arrow indicating direction of insertion

Remove the vial adapter

Hold the syringe by the white ring and unscrew it from the vial adapter.

Properly dispose of both the vial and the vial adapter.

Step 3

Place the needle

Scheme of the deltoid muscle with indication of 1 inch and preloaded syringe pointing towards the upper muscular area of the armPreloaded syringe with needle inserted into the gluteus at a depth of 2 inches, arrow indicating injection site

Select the appropriate needle

Select the needle according to the injection site (gluteus or deltoid).

Hand holding an autoinjector with an exposed needle and a circle with an arrow indicating the direction of insertion

Place the needle

Open the blister pack by the partially detached area and use it to grasp the base of the needle, as shown.

Holding the white ring of the syringe,attach the syringe to the luer needle with a firm clockwise rotationuntil it is secure.

Do nottouch the luer needle opening. This can lead to contamination.

Hand holding an autoinjector with arrows indicating rotation and pressure to activate the device

Resuspend the microspheres

Completely remove the blister pack.

Just before injection, vigorously shake the syringe again, in case any sedimentation has occurred.

Step 4

Inject the dose

Hands holding a preloaded injection device with a connected needle, arrows indicating direction of insertion

Remove the transparent needle protector

Move the needle safety device towards the syringe, as shown.

Then, holding the white ring of the syringe, carefully remove the transparent needle protector.

Do nottwist the transparent needle protector, as the luer connection may be lost.

Hand holding a syringe with a needle inserted into the skin, showing a retracted safety device with an arrow indicating direction

Eliminate air bubbles

Hold the syringe upright and gently tap to make the air bubbles reach the top.

Slowly and carefully, press the plunger rod to eliminate the air.

Human torso with black arrows pointing to the upper arm and the side of the chest

Inject

Immediately inject all the contents of the syringe intramuscularly (IM) into the gluteus or the deltoid muscle of the patient.

The gluteal injection should be given in the upper outer quadrant of the gluteus.

Do not administer intravenously.

Hand pinching the skin with the thumb and index finger, preparing for a subcutaneous injection with a short needle

Protect the needle in the safety device

Using one hand, place the needle safety device at a 45-degree angle on a flat, hard surface. Press down firmly and quickly until the needle is completely inside the safety device.

To avoid a needlestick:

Do notuse two hands.

Do notdeliberately disconnect or mishandle the needle safety device.

Do notattempt to straighten the needle or attach the safety device if the needle is bent or damaged.

Used needle being discarded in a white container with a biological hazard symbol and an open lid

Properly dispose of the needles

Check that the needle safety device is completely attached.

Dispose of it in a container for used needles.

Also, dispose of the unused needle provided in the pack and the unused dose.

Online doctors for RISPERIDONE TEVA 37.5 mg POWDER AND SOLVENT FOR PROLONGED-RELEASE INJECTABLE SUSPENSION

Discuss questions about RISPERIDONE TEVA 37.5 mg POWDER AND SOLVENT FOR PROLONGED-RELEASE INJECTABLE SUSPENSION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (5)
Doctor

Anastasiia Hladkykh

Psychiatry 15 years exp.

Dr Anastasiia Hladkykh is a physician-psychotherapist and psychologist with over 14 years of experience working with individuals struggling with various types of addictions and their families. She provides online consultations for adults, combining medical knowledge with deep psychological support and practical tools.

Key areas of expertise:

  • Addiction treatment: alcohol and drug dependence, gambling addiction, compulsive behaviours, codependent relationships.
  • Support for families of addicted individuals, behavioural correction within the family system, guidance for maintaining remission.
  • Mental health: depression, bipolar disorder, obsessive-compulsive disorder (OCD), anxiety disorders, phobias, PTSD, generalised anxiety, emotional trauma, and the psychological impact of loss or emigration.
  • Psychoeducation: explaining complex mental health concepts in simple language, helping patients and their families understand diagnoses and treatment steps.
Therapeutic approach:
  • Client-centred, straightforward, and empathetic – focused on practical outcomes and emotional stabilisation.
  • Prescribes medications when needed, but always aims to minimise unnecessary pharmaceutical use.
  • Certified in multiple evidence-based methods: CBT, NLP (Master Practitioner), Ericksonian hypnosis, symbol drama, art therapy, and systemic therapy.
  • Each consultation results in a clear, structured plan – patients leave knowing exactly what to do next.
Experience and background:
  • Member of the German association Gesundheitpraktikerin and the NGO “Mit dem Sonne in jedem Herzen.”
  • More than 18 publications in international peer-reviewed journals, translated into several languages.
  • Volunteer work with Ukrainian refugees and military personnel at the University Clinic of Regensburg.
Camera Book a video appointment
€130
0.0 (1)
Doctor

Daria Portnova

Psychiatry 31 years exp.

Dr Daria Portnova is a psychiatrist and psychotherapist with over 30 years of clinical experience. She works with adults and adolescents aged 14 and over, providing online psychiatric and psychotherapeutic consultations.

In her practice, Dr Portnova supports patients facing the onset of mental health conditions, chronic psychiatric disorders, psychotic symptoms, trauma-related states, and complex emotional crises. Her work is structured and safety-focused, with an emphasis on stabilisation, accurate diagnosis, and long-term improvement in quality of life.

Patients consult Dr Daria Portnova for the following concerns:

  • existential crises and complex life situations;
  • loss, grief, and emotional exhaustion;
  • relationship difficulties, separation, and divorce;
  • psychological and psychiatric trauma, including complex PTSD (cPTSD);
  • anxiety disorders: generalised anxiety disorder and panic disorder;
  • social anxiety and social phobia;
  • obsessive-compulsive disorder (OCD);
  • sleep disorders;
  • depressive disorders;
  • bipolar affective disorder;
  • schizoaffective disorder;
  • schizophrenia;
  • personality disorders.
Dr Portnova combines psychiatric assessment with a psychotherapeutic approach. She works with evidence-based methods, including cognitive behavioural therapy (CBT) and third-wave approaches such as ACT, FACT, and CFT. Consultations are focused on clear clinical understanding, practical recommendations, and ongoing support over time.
Camera Book a video appointment
€110
5.0 (77)
Doctor

Sergey Ilyasov

Psychiatry 7 years exp.

Dr Sergey Ilyasov is an experienced neurologist and qualified psychiatrist who provides online consultations for adults and adolescents. Combining deep neurological expertise with a modern psychiatric approach, he ensures comprehensive diagnostics and effective treatment for a wide range of conditions affecting both physical and mental health.

Dr. Ilyasov helps patients in the following cases:

  • Chronic headaches (migraine, tension-type headache), back pain, neuropathic pain, dizziness, numbness in limbs, coordination disorders.
  • Anxiety disorders (panic attacks, generalized anxiety disorder), depression (including atypical and treatment-resistant forms), sleep disturbances (insomnia, hypersomnia, nightmares), stress, burnout.
  • Chronic pain syndromes and psychosomatic symptoms (e.g., irritable bowel syndrome related to stress, vegetative-vascular dystonia).
  • Behavioral disorders and concentration difficulties in adolescents (including ADHD, autism spectrum disorders), nervous tics.
  • Memory impairments, phobias, obsessive-compulsive disorder (OCD), emotional swings, and support for post-traumatic stress disorder (PTSD).

Thanks to his dual specialization in neurology and psychiatry, Dr Sergey Ilyasov offers integrated and evidence-based care for complex conditions requiring a multidisciplinary approach. His consultations focus on accurate diagnosis, development of an individualized treatment plan (including pharmacotherapy and psychotherapeutic methods), and long-term support adapted to each patient's unique needs.

Book an online consultation with Dr. Sergey Ilyasov to receive qualified assistance and improve your well-being today.

Camera Book a video appointment
€89
5.0 (137)
Doctor

Taisiia Proida

Psychiatry 7 years exp.

Dr. Taisiia Proida is a psychiatrist and cognitive behavioural therapist (CBT), and a member of the European Psychiatric Association. She offers online consultations for adults aged 18 and over, combining evidence-based medicine with an individualised approach to mental health care.

She specialises in consultations and ongoing support for a wide range of mental health concerns, including:

  • Mood disorders: depression, bipolar disorder, postpartum depression.
  • Anxiety disorders: generalised anxiety, OCD, panic attacks, phobias.
  • Post-traumatic stress disorder (PTSD) and complex PTSD.
  • Attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Assessment is provided only after an initial psychiatric evaluation and during a follow-up appointment.
  • Personality disorders and emotional instability.
  • Cyclothymia and mood fluctuations.
  • Schizophrenia spectrum and related conditions.

Dr. Proida combines clinical expertise with an empathetic approach, offering structured support based on evidence-based practices. Her work integrates CBT techniques with medical management, with a focus on anxiety and depressive disorders.

She works with clients from different countries and cultural backgrounds, adapting her communication style and recommendations to individual needs. With experience in international clinical trials (Pfizer, Merck), she values clarity, trust, and collaborative partnership in patient care.

Camera Book a video appointment
€120

Frequently Asked Questions

Is a prescription required for RISPERIDONE TEVA 37.5 mg POWDER AND SOLVENT FOR PROLONGED-RELEASE INJECTABLE SUSPENSION?
RISPERIDONE TEVA 37.5 mg POWDER AND SOLVENT FOR PROLONGED-RELEASE INJECTABLE SUSPENSION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in RISPERIDONE TEVA 37.5 mg POWDER AND SOLVENT FOR PROLONGED-RELEASE INJECTABLE SUSPENSION?
The active ingredient in RISPERIDONE TEVA 37.5 mg POWDER AND SOLVENT FOR PROLONGED-RELEASE INJECTABLE SUSPENSION is risperidone. This information helps identify medicines with the same composition but different brand names.
How much does RISPERIDONE TEVA 37.5 mg POWDER AND SOLVENT FOR PROLONGED-RELEASE INJECTABLE SUSPENSION cost in pharmacies?
The average pharmacy price for RISPERIDONE TEVA 37.5 mg POWDER AND SOLVENT FOR PROLONGED-RELEASE INJECTABLE SUSPENSION is around 103.7 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures RISPERIDONE TEVA 37.5 mg POWDER AND SOLVENT FOR PROLONGED-RELEASE INJECTABLE SUSPENSION?
RISPERIDONE TEVA 37.5 mg POWDER AND SOLVENT FOR PROLONGED-RELEASE INJECTABLE SUSPENSION is manufactured by Teva Pharma S.L.U.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of RISPERIDONE TEVA 37.5 mg POWDER AND SOLVENT FOR PROLONGED-RELEASE INJECTABLE SUSPENSION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether RISPERIDONE TEVA 37.5 mg POWDER AND SOLVENT FOR PROLONGED-RELEASE INJECTABLE SUSPENSION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to RISPERIDONE TEVA 37.5 mg POWDER AND SOLVENT FOR PROLONGED-RELEASE INJECTABLE SUSPENSION?
Other medicines with the same active substance (risperidone) include ARKETIN 1 mg FILM-COATED TABLETS, ARKETIN 3 mg FILM-COATED TABLETS, ARKETIN 6 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media